Status:
COMPLETED
Next Generation Ophthalmic Irrigating Solution Posterior Segment Study
Lead Sponsor:
Alcon Research
Conditions:
Eye Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the safety of Next Generation Ophthalmic Irrigating Solution (NGOIS) compared to BSS PLUS for use during surgery for removal of epimacular membrane and vitrect...
Eligibility Criteria
Inclusion
- Patients of any race and sex, with an epimacular membrane who would benefit from vitrectomy and membrane removal.
- Other protocol-defined inclusion criteria may apply.
Exclusion
- Under 18 years of age.
- Other protocol-defined exclusion criteria may apply.
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2006
Estimated Enrollment :
369 Patients enrolled
Trial Details
Trial ID
NCT00333203
Start Date
October 1 2005
End Date
March 1 2006
Last Update
March 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
United States
Fort Worth, Texas, United States, 76134